Catheter Precision Inc. has entered into a Securities Purchase Agreement with three investors on May 12, 2025. The company sold a total of 1.5 million shares of its newly designated Series B Convertible Preferred Stock for a stated value of $1.5 million. Additionally, Catheter Precision issued another 1.5 million shares of the same stock as consideration to one investor in exchange for existing senior secured Convertible Promissory Notes of QHSLab, Inc. A total of 8,574,000 shares of common stock have been reserved for issuance upon conversion of the Series B Convertible Preferred Stock.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-016188), on May 13, 2025, and is solely responsible for the information contained therein.